Physician profile
Evan E Neft
NPI 1568623700
$3,510.23
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,269 · 2020: $933 · 2021: $1,239 · 2023: $30.03 · 2024: $39.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $586.50 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $377.13 | 2019-2021 | |
| Novo Nordisk INC | $360.03 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $345.88 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $275.66 | 2019-2021 | |
| Glaxosmithkline, LLC. | $215.60 | 2019-2021 | |
| Abbvie INC. | $177.38 | 2021 | |
| Bausch Health US, LLC | $175.05 | 2019-2021 | |
| Pfizer INC. | $149.24 | 2019-2021 | |
| Lilly USA, LLC | $141.22 | 2019-2021 | |
| Allergan, INC. | $101.36 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $100.03 | 2019-2021 | |
| Eisai INC. | $91.32 | 2020-2021 | |
| Inspire Medical Systems, INC. | $69.60 | 2023-2024 | Inspire |
| Amarin Pharma, INC. | $58.12 | 2020-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $41.09 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.19 | 2019 | |
| Avanir Pharmaceuticals, INC. | $28.73 | 2019 | |
| Shire North American Group INC | $21.36 | 2019 | |
| Abbott Laboratories | $20.88 | 2021 | |
| Lundbeck LLC | $20.58 | 2021 | |
| Genentech USA, INC. | $20.54 | 2019 | |
| Philips North America LLC | $20.06 | 2019 | |
| Adlon Therapeutics L.P. | $18.46 | 2021 | |
| Pacira Therapeutics, INC. | $17.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.52 | 2021 | |
| Sanofi Pasteur INC. | $15.17 | 2019 | |
| Hologic Sales and Service, LLC | $14.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Neft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.